Search Results - "Fothergill, A.W."

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    The in vitro elution characteristics of antifungal-loaded PMMA bone cement and calcium sulfate bone substitute by Grimsrud, Christopher, Raven, Raymond, Fothergill, A W, Kim, Hubert T

    Published in Orthopedics (Thorofare, N.J.) (08-08-2011)
    “…The use of antimicrobial-loaded delivery vehicles, most often as antibiotic beads, is common practice for the treatment of deep musculoskeletal infections. The…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Spectrum of Clinically Relevant Acremonium Species in the United States by Perdomo, H, Sutton, D.A, García, D, Fothergill, A.W, Cano, J, Gené, J, Summerbell, R.C, Rinaldi, M.G, Guarro, J

    Published in Journal of Clinical Microbiology (01-01-2011)
    “…Some species in the polyphyletic fungal genus Acremonium are important opportunist pathogens. Determining the actual spectrum of species and their incidence in…”
    Get full text
    Journal Article
  4. 4

    Spectrum of Zygomycete Species Identified in Clinically Significant Specimens in the United States by Alvarez, E, Sutton, D.A, Cano, J, Fothergill, A.W, Stchigel, A, Rinaldi, M.G, Guarro, J

    Published in Journal of Clinical Microbiology (01-06-2009)
    “…Several members of the order Mucorales (subphylum Mucoromycotina) are important agents of severe human infections. The identification of these fungi by using…”
    Get full text
    Journal Article
  5. 5

    In vitro antifungal susceptibility and molecular identity of 99 clinical isolates of the opportunistic fungal genus Curvularia by da Cunha, Keith C, Sutton, Deanna A, Fothergill, Annette W, Gené, Josepa, Cano, Josep, Madrid, Hugo, Hoog, Sybren de, Crous, Pedro W, Guarro, Josep

    “…Abstract The in vitro antifungal susceptibility of a set of 99 clinical isolates of Curvularia was tested against 9 drugs using a reference microdilution…”
    Get full text
    Journal Article
  6. 6

    Diversity of Bipolaris Species in Clinical Samples in the United States and Their Antifungal Susceptibility Profiles by DA CUNHA, K. C, SUTTON, D. A, FOTHERGILL, A. W, CANO, J, GENE, J, MADRID, H, DE HOOG, S, CROUS, P. W, GUARRO, J

    Published in Journal of Clinical Microbiology (01-12-2012)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  7. 7

    Molecular Phylogeny and Proposal of Two New Species of the Emerging Pathogenic Fungus Saksenaea by Alvarez, E, Garcia-Hermoso, D, Sutton, D.A, Cano, J.F, Stchigel, A.M, Hoinard, D, Fothergill, A.W, Rinaldi, M.G, Dromer, F, Guarro, J

    Published in Journal of Clinical Microbiology (01-12-2010)
    “…Saksenaea is a monotypic genus belonging to the order Mucorales and capable of producing severe human infections. Through a polyphasic study based on analysis…”
    Get full text
    Journal Article
  8. 8

    In Vitro Natamycin Susceptibility of Ocular Isolates of Fusarium and Aspergillus Species: Comparison of Commercially Formulated Natamycin Eye Drops to Pharmaceutical-Grade Powder by Lalitha, P, Vijaykumar, R, Prajna, N.V, Fothergill, A.W

    Published in Journal of Clinical Microbiology (01-10-2008)
    “…The Clinical and Laboratory Standards Institute susceptibility method prohibits the use of pharmacy preparations, but obtaining pure powders is difficult. The…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Osteomyelitis caused by Aspergillus species: a review of 310 reported cases by Gabrielli, E., Fothergill, A.W., Brescini, L., Sutton, D.A., Marchionni, E., Orsetti, E., Staffolani, S., Castelli, P., Gesuita, R., Barchiesi, F.

    Published in Clinical microbiology and infection (01-06-2014)
    “…Aspergillus osteomyelitis is a rare infection. We reviewed 310 individual cases reported in the literature from 1936 to 2013. The median age of patients was 43…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    In vitro activity of voriconazole against selected fungi by McGinnis, M.R., Pasarell, L., Sutton, D.A., Fothergill, A.W., Cooper, C.R., Rinaldi, M.G.

    Published in Medical mycology (Oxford) (01-01-1998)
    “…Fifty-nine isolates consisting of 14 genera and 33 species of ascomycetes, basidiomycetes, and zygomycetes were tested against amphotericin B, fluconazole,…”
    Get full text
    Journal Article
  14. 14

    In vitro efficacy of lufenuron against filamentous fungi and blood concentrations after PO administration in horses by Scotty, N.C, Evans, T.J, Giuliano, E, Johnson, P.J, Rottinghaus, G.E, Fothergill, A.W, Cutler, T.J

    Published in Journal of veterinary internal medicine (01-11-2005)
    “…Lufenuron is a benzoylphenyl urea‐derived insecticide that has been recently introduced as a novel treatment for fungal infections in horses. The purposes of…”
    Get full text
    Journal Article
  15. 15

    Pradimicin therapy of disseminated Candida tropicalis infection in the mouse by Restrepo, M.I., Najvar, L.K., Fothergill, A.W., Graybill, J.R.

    Published in Medical mycology (Oxford) (01-06-1998)
    “…BMS 181184 (BMS), an analogue of pradimicin, was administered intravenously to neutropenic mice infected with either a fluconazole-susceptible or a…”
    Get full text
    Journal Article
  16. 16

    Discrepancy between in vitro and in vivo antifungal activity of albendazole by Hardin, T. C., Najvar, L. K., Rizzo, J., Fothergill, A. W., Rinaldi, M. G., Graybill, J. R.

    Published in Journal of medical and veterinary mycology (01-05-1997)
    “…Albendazole has in vitro activity against Cryptococcus neoformans and reduced in vitro activity for albendazole when compared with Candida albicans. The major…”
    Get full text
    Journal Article